Juzhen Yan

Juzhen Yan

Auto-generated profile, based on publicly available information

Juzhen Yan

Department of Rheumatology and Immunology, Hangzhou Normal University Affiliated Hospital, Hangzhou, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2020 in Naunyn-Schmiedeberg's Archives of Pharmacology
Verified
Journal Article
Closed access
PDF file
YHYang Huang
Yang Huang
GYGuangxia Yang
Guangxia Yang
JFJing Fei
Jing Fei
YWYingyi Wu
Yingyi Wu
JYJuzhen Yan
Juzhen Yan

1 April 2022 in Translational Andrology and Urology
Verified
Journal Article
Open access
PDF file
YSYezhou Shen
Yezhou Shen
JYJiaoyang Yu
Jiaoyang Yu
ZFZhou Fei
Zhou Fei
JYJuzhen Yan
Juzhen Yan
JYJing Yang
Jing Yang
LLLeqing Lin
Leqing Lin
Background: The purpose of this study was to evaluate the accuracy of the lactate clearance rate (LCR) combined with the Acute Physiology and Chronic Health Evaluation II (APACHE II) score in the prediction of sepsis-associated acute kidney injury (SAKI). Methods: Sepsis patients were divided into the SAKI group and non-SAKI group. Arterial blood lactate was collected at 0 h (before treatment), 2 h, 4 h, 6 h, and 8 h (after treatment), and the LCR was calculated. The physiological parameters and laboratory test results were used to calculate the APACHE II score and the Sequential Organ Failure Assessment (SOFA) score. The receiver operating characteristic (ROC) curves of LCR, APACHE II score and SOFA score for predicting patients with SAKI were drawn. Two single indicators with high areas under the curves (AUCs) were selected to calculate the joint probability through regression analysis, and the prediction efficiency corresponding to each curve was analyzed. Results: There were significant differences in LCR between different groups and time periods (Fgroup=17.44, Pgroup ≤0.0001, Ftime =11.71, Ptime =0.0014). After 8 h of treatment, there was a significant difference in the overall compliance rate between the 2 groups (P<0.0001). In addition, after 24 h of treatment, the APACHE II score in the SAKI group was significantly higher than that in the non-SAKI group (P=0.0007), and SOFA score was also significantly higher than that in the non-SAKI group (P=0.0001). ROC curve showed that the 0–8 h LCR and APACHE II scores had a high predictive performance for the acute kidney injury (AKI) occurrence in sepsis patients, and AUCs were 0.7637 and 0.7517, respectively, while the combined AUC of the 2 indicators was 0.7975. Conclusions: The 0–8 h LCR combined with APACHE II score can improve the early predictive value of SAKI, reduce the risk of AKI in patients with sepsis/septic shock, and reduce the social and family burden, which is worthy of clinical application.

20 May 2021 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
PHPingyang Han
Pingyang Han
CSChen Sun
Chen Sun
YZYinghong Zhang
Yinghong Zhang
JYJuzhen Yan
Juzhen Yan

27 May 2023 in International Journal of Rheumatic Diseases
Verified
Journal Article
Closed access
PHPingyang Han
Pingyang Han
CSChen Sun
Chen Sun
JYJuzhen Yan
Juzhen Yan

8 November 2024 in Central European Journal of Immunology
Verified
Journal Article
Open access
CSChen Sun
Chen Sun
PHPingyang Han
Pingyang Han
JYJuzhen Yan
Juzhen Yan
22q11.2 deletion syndrome (MIM: 192430/188400, ORPHA: 567) is the most common chromosomal microdeletion disorder, caused by a hemizygous microdeletion of 2.5 million base pairs on chromosome 22. There is a known association between 22q11.2 deletion syndrome (22q11.2DS), immunodeficiency and autoimmune diseases. However, the co-occurrence of 22q11.2DS and systemic lupus erythematosus (SLE) has been rarely reported. Here, we describe a case of a female teenager with distal type I 22q11.2DS who presented with alopecia, oral ulcers, fever and thrombocytopenia. Laboratory tests showed positive antinuclear antibodies (ANA) and double-stranded DNA (ds-DNA) antibodies, indicative of SLE. Treatment with prednisone, hydroxychloroquine and azathioprine resulted in improvement. We reviewed the literature on the immunological mechanisms involved in 22q11.2DS. Thymic dysplasia, T-cell lymphopenia, and B-cell abnormalities collectively contribute to the immunodeficiency and autoimmune manifestations observed in individuals with 22q11.2DS. Genetic factors such as 22q11.2DS should be considered in the diagnosis of childhood rheumatic diseases. Our case adds to the limited literature on this co-occurrence.